SPY424.27-0.99 -0.23%
DIA343.06-1.24 -0.36%
IXIC14,085.26-88.89 -0.63%

BRIEF-Aurinia Announces Publication Of Aurora 1 Phase 3 Study Results

05/10/2021 07:16
BRIEF-Aurinia Announces Publication Of Aurora 1 Phase 3 Study Results

- Aurinia Pharmaceuticals Inc AUP.TO:

  • AURINIA ANNOUNCES PUBLICATION OF AURORA 1 PHASE 3 STUDY RESULTS WITH LUPKYNIS™ (VOCLOSPORIN) IN THE LANCET

  • AURINIA PHARMACEUTICALS INC - STUDY RESULTS DEMONSTRATE THAT LUPKYNIS IN COMBINATION WITH TYPICAL STANDARD OF CARE

Source text for Eikon: ID:nBw5S2fhha

Further company coverage: AUP.TO


(([email protected];))